Identifícate
Grupos
Investigadores/as
Resultados
HOSPITAL UNIVERSITARIO RUBER
Departamento
First Hospital of Jilin University
Changchun, China
Estás en
Colaboracións
First Hospital of Jilin University
Publicacións en colaboración con investigadores/as de First Hospital of Jilin University (2)
2023
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
The Lancet, Vol. 401, Núm. 10371, pp. 105-117
2016
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): An open-label, randomised, phase 3 trial
The Lancet Oncology, Vol. 17, Núm. 3, pp. 357-366
Contactar
Aviso legal
Axuda
translate
gl
arrow_drop_down
translate
gl
arrow_drop_down
es
ca
eu
en
fr
de